Novartis Institutes for BioMedical Research (US): Director Biotherapeutics, Oncology

At Novartis Institutes for BioMedical Research (NIBR), the global research organization of Novartis, we are committed to discovering innovative medicines to cure disease and improve human health. By hiring the best academic, biotech, and pharmaceutical trained scientists, we have fostered an atmosphere for drug discovery where innovation is rewarded. It is ultimately the talent of the individual that determines our success, while our state-of-the-art technologies and resources enable these ideas to be realized.

NIBR has sites in Cambridge, Massachusetts; Emeryville, CA; Basel, Switzerland; Horsham, UK; and Shanghai, China. Our Emeryville location focuses on early drug discovery efforts for the Oncology and Infectious Disease Areas and offers a variety of positions in Biology, Chemistry, and functions such as Technology, Patents, Research Sciences and other areas that support our scientific resources.

About the Biological Therapeutics Group

Novartis is committed to developing biologics as drugs, and the company is making significant investments in this area throughout the organization. In the Biological Therapeutics group in Emeryville, our focus is on the development of biologics for the treatment of cancer patients. In particular, we work on the generation and characterization of therapeutic antibodies and antibody-like molecules, as well as the identification and validation of the targets that serve as the basis for the new drug development activities.

About the position:

We are seeking a highly motivated and innovative senior research scientist with demonstrated expertise in cancer biology, a keen interest in target discovery, novel antibody generation technologies, and experience in biologics drug development to lead a dynamic group dedicated to the discovery and development of novel biotherapeutics for cancer. In particular, this position will focus on the development of antibody drug conjugates, and novel biologic format drugs for a variety of cancer indications. The successful candidate will be responsible for defining the strategy and for building creative approaches to discover and progress antibody-based therapies for cancer. The candidate will oversee and be responsible for a large research group that does discovery, validation, selection, and characterization of drug candidates and that helps define the clinical utility of its projects.

As the Director of the Biotherapeutics Oncology group you will be required to supervise and develop PhD/BS/MS level scientists, manage programs and deliverable, timelines and budgets. You will be a member of the Emeryville Oncology site leadership team, as well as a senior member of the global oncology team. This position requires excellent organizational skills, creativity, enthusiasm and the ability to work in a highly collaborative matrixed global environment. The successful candidate will be expected to possess a significant experience in bringing biologics into early clinical development and have a robust publication record.

Minimum requirements               Qualifications:

• Ph.D. in Oncology, Tumor Immunology, Cell Biology, or other relevant field, with at least 15 years of postgraduate experience.

• Demonstrated solid track record of scientific achievements and strong leadership in matrix-based environment is essential.

• In depth knowledge of cancer-associated signaling pathways and/or models of cancer is required.

• In-depth knowledge of biologics drug discovery and experience with transitioning biological therapeutics projects into the clinic required.

• Experience in antibody drug conjugates and novel Antibody formats preferred, and a demonstrated track record of innovation required

• Exceptional written, verbal, and team communication skills are essential.

• Excellent management skills and demonstrated ability to work with and mentor PhD and non-PhD level scientists

   Share on:        

The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis committed to discovering innovative medicines to treat diseases with high unmet medical need.

Comments

Post a Comment

Popular posts from this blog

Protein folding via charge zippers

Jan. 18, 2013 — Membrane proteins are the "molecular machines" in biological cell envelopes. They control diverse processes, such as the transport of molecules across the lipid membrane, signal transduction, and photosynthesis. Their shape, i.e. folding of the molecules, plays a decisive role in the formation of, e.g., pores in the cell membrane. In the journal Cell, researchers of Karlsruhe Institute of Technology and the University of Cagliari are now reporting a novel charge zipper principle used by proteins to form functional units. "It is fascinating to see the elegant basic principles that are used by nature to construct molecular assemblies," explains Anne Ulrich, Director of the KIT Institute for Biological Interfaces. "A charge zipper between the charged side chains is an entirely unexpected mechanism used by membrane proteins to neutralize their charges such that they can be immersed into hydrophobic cell membranes....
Read more

Lonza: CMC Product Manager

Due to the expansion of Lonza's Analytical Services department we are looking to recruit an Analytical Product Manager. Reporting to the Group Leader you will proactively coordinate internal and external client project activities (analytical CMC development of recombinant proteins) performed within Analytical Services and to provide scientific oversight of data generated for the projects. Responsibilities:      * Primary point of contact for all analytical activities relating to product development and management of analytical development programmes from early phase development through to license application.      * Primary interface to the Program Management Team, AS study directors and internal and external customers.      * Definition, presentation and representation of analytical CMC programmes to customers, potential new customers & external meetings, including oversight of large analytical portfolio projects.      * Design an...
Read more

GlaxoSmithKline (GSK): Esprit Physician Leadership Development Programme

Esprit Physician Leadership Development Programme Are you an MBBS or MD with experience gained in a pharmaceutical, biotech or academic environment eager to become an outstanding leader? An inquisitive mind who would thrive on a diverse, intellectually demanding global leadership programme? Do you want to translate your medical expertise into disease-beating medicines? And help people across the world to do more, feel better and live longer? We are a science-led, global healthcare company that puts patients first. Our business is focused on developing medicines that improve the quality of human life. To meet the future strategic challenges this entails, we need to fast-track the finest medical talent into senior leadership roles within our business. The Esprit Physician programme is an initial three-year, accelerated, multi-disciplinary and individually tailored programme. It is heavily backed by our senior management team, and it will give you incredible standing as a phys...
Read more